Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tutogen Tasks New CEO With Reinstituting Independent Business Strategy

This article was originally published in The Gray Sheet

Executive Summary

Tutogen Medical expects former Zimmer exec Guy Mayer, who becomes CEO Jan. 1, 2005, to lead the company forward as a successful stand-alone entity by ramping up sales of its Tutoplast sterile tissue business

You may also be interested in...



People In Brief

Thoratec: HeartMate left-ventricular assist device manufacturer revamps its team of cardiovascular division VPs, with David Farrar, PhD, being assigned to the newly created post of VP-research & scientific affairs. Farrar previously was VP-research & development. Laxmi Peri, formerly with St. Jude Medical, takes over as VP-technology & product development and Steven Brandt assumes the VP-sales & marketing position. All three will work to promote adoption of HeartMate XVE, the only available destination LVAD in the U.S., and on HeartMate II development, for which the company expects to receive approval for a pivotal trial by March 14. Debbie Schultz also has joined as senior director of customer-driven quality. She previously was VP-customer support for ADAC Lab/Philips Medical. The CFO slot remains open, following Wayne Boylston's resignation in December...

People In Brief

Thoratec: HeartMate left-ventricular assist device manufacturer revamps its team of cardiovascular division VPs, with David Farrar, PhD, being assigned to the newly created post of VP-research & scientific affairs. Farrar previously was VP-research & development. Laxmi Peri, formerly with St. Jude Medical, takes over as VP-technology & product development and Steven Brandt assumes the VP-sales & marketing position. All three will work to promote adoption of HeartMate XVE, the only available destination LVAD in the U.S., and on HeartMate II development, for which the company expects to receive approval for a pivotal trial by March 14. Debbie Schultz also has joined as senior director of customer-driven quality. She previously was VP-customer support for ADAC Lab/Philips Medical. The CFO slot remains open, following Wayne Boylston's resignation in December...

Zimmer Projects Earnings Growth Acceleration Through 2006 After Merger

Zimmer expects up to $50 mil. in sales "dis-synergies" in 2004 related to the integration of its distributors and sales reps with those of Centerpulse

Related Content

UsernamePublicRestriction

Register

MT021321

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel